Consultant – Formulation Microparticle Development (PLGA) (HFX)
International consulting group founded in 2019 Ekkiden fosters an ecosystem of passionate and committed consultants who lead organizational operational and technological transformation projects in IT/Digital Industry/R&D and Sustainability for large corporations and SMEs in France Switzerland Spain and Germany.
As part of the final stage of development of new subcutaneous injectable products based on dried PLGA microparticles and compatible diluents we are looking for an expert to reinforce our R&D team.
These products are sustained-release formulations intended for endocrinology applications.
This project is part of an international dynamic:
Analytical development activities outsourced to the Netherlands
Process development laboratory located in Switzerland with collaborating teams in Berlin
Integration planned for January 2026 with an expanded team in Copenhagen
The objective is to consolidate technical resources to finalize formulation development and prepare the next industrial and regulatory milestones.
Contribute to the late-stage development of PLGA-based drug products (dried microparticles microsphere-based powders reconstitution/diluent systems for SC injection).
Support optimization and finalization of formulation parameters and manufacturing processes for sustained-release PLGA microparticles.
Collaborate closely with the current development lead (15 years of experience) on formulation robustness scale-up considerations and product characterization (particle size morphology encapsulation efficiency in vitro release rheology reconstitution properties etc.).
Participate in inter-site knowledge transfer as the project transitions to larger teams.
Provide scientific and technical support to external partners (contract labs analytical consultants device & packaging specialists).
Contribute to drafting and reviewing technical and regulatory documentation including protocols reports specifications and risk assessments.
(Plus) Contribute to preclinical readiness activities; experience performing or supporting in vivo rat studies is strongly valued.
What were looking for:
Advanced degree in chemistry pharmaceutics galenics chemical engineering or biotechnology (Masters/PhD).
610 years of experience developing microparticle or microsphere formulations based on PLGA or related biodegradable polymers.
Strong expertise in pharmaceutical formulation process development and characterization of sustained-release injectable products.
Experience working on subcutaneous administration products ideally involving dried or reconstitutable microparticle systems.
Knowledge of GMP norms and expectations for late-stage CMC development; prior exposure to preparing for scale-up or validation is a plus.
Experience with in vivo testing preferably rodent (rat) models is a significant asset.
Good understanding of analytical techniques and primary packaging requirements (vials syringes dual-chamber systems etc.).
Experience in a pharmaceutical or biotechnology environment.
Fluent in English; French or German is a plus.
Occasional travel possible to Copenhagen or Berlin.
Required Experience:
Contract
Key Skills
Computer,Automation,Electronics Engineering,Key Account,Chemistry
Employment Type : Full-Time
Experience: years
Vacancy: 1
Créer une alerte emploi pour cette recherche
Consultant Formulation Microparticle Development PLGA HFX • Lausanne, Vaud, Switzerland
%20AG){kind=logo}
Décolleteur CNC Citizen & Tsugami
Mécanicien Outilleur / Spécialiste Étampes (H/F)
Head of Product Quality & Reliability
R&D formulation scientist
Production Engineer
Mécanicien Prototypiste (h/f)
Décolleteur CNC - 2x8
R&D engineer
Senior Industrialisation Project Manager – MedTech
Supply chain planner
Quality Engineer
Polymechanic
Ingénieur HES Microtechnique / Génie Industriel - JUNIOR (H/F)
Expert Transfert Industriel
Hardware Engineer
Galvanoplaste
Process Engineer
